Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines (Style Trial)
Clinical trial NCT03449173 · UNKNOWN
Trial details
- NCT number
- NCT03449173
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-02
- Primary completion
- 2022-05-31
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.